Trial intelligence / Profile preview

Testosterone for Aromatase Inhibitor Induced Arthralgia

NCT01573442Phase 3Completed

Sponsor
Cancer and Leukemia Group B
Start
Sep 2013
Primary completion
Feb 2018
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of testosterone in arthralgia, sponsored by Cancer and Leukemia Group B. Started Sep 2013; status: completed.

02

Drugs

testosterone
03

Conditions

arthralgia

Beyond the preview

Go deeper on NCT01573442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01573442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call